The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Share News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 733.00
Bid: 733.00
Ask: 735.00
Change: -3.00 (-0.41%)
Spread: 2.00 (0.273%)
Open: 737.00
High: 737.00
Low: 731.00
Prev. Close: 736.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bodycote YTD revenues grow

Wed, 22nd Nov 2023 08:04

(Sharecast News) - Heat treatments firm Bodycote said on Wednesday that year-to-date revenues had improved, as ADE revenue growth helped offset weakness in emerging markets.

Bodycote said it had delivered year-to-date revenues of £677.0m, representing growth of 10% year-on-year and 6% when excluding energy-related surcharges and at constant currency.

In the four months ended 31 October, Bodycote delivered revenues of £257.0m, up 4% year-on-year at constant currency on both a pre and post-surcharge basis. Operating margins increased in line with internal expectations.

ADE revenues were up 10% at £116.0m and AGI revenues were down 1% at £140.0m, while divisional revenues in emerging markets declined by 7%, with lower activity in China and Eastern Europe.

The FTSE 250-listed group stated that as a result of the "good progress achieved year-to-date, its expectations for full-year remained unchanged. Looking beyond this year, Bodycote said it was "confident" in its prospects for continued profitable growth.

As of 0935 GMT, Bodycote shares were down 0.42% at 591.0p.

Reporting by Iain Gilbert at Sharecast.com

More News
16 Mar 2021 09:39

BROKER RATINGS: CS upgrades HSBC, Barclays and NatWest, cuts StanChart

BROKER RATINGS: CS upgrades HSBC, Barclays and NatWest, cuts StanChart

Read more
12 Mar 2021 08:32

TOP NEWS: Bodycote outlook confident despite swing to loss in 2020

TOP NEWS: Bodycote outlook confident despite swing to loss in 2020

Read more
12 Mar 2021 07:36

Bodycote revenues, profits fall as it repositions business

(Sharecast News) - Bodycote's revenues fell 16.9% in 2020 to £598m, it said on Friday, as its organic revenues declined 20%.

Read more
5 Mar 2021 15:56

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Feb 2021 13:46

Tuesday broker round-up

(Sharecast News) - Spirent Communications: Canaccord upgrades to buy with a target price of 275p.

Read more
9 Feb 2021 09:31

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

Read more
5 Feb 2021 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
20 Jan 2021 09:40

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood

Read more
18 Jan 2021 09:34

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

Read more
15 Jan 2021 09:38

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

Read more
31 Dec 2020 17:12

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Dec 2020 09:50

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

UK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group

Read more
3 Dec 2020 09:34

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform

Read more
30 Nov 2020 13:40

Monday broker round-up

(Sharecast News) - Bodycote: JP Morgan downgrades to underweight with a target price of 635p.

Read more
30 Nov 2020 09:49

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.